The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 628,159,958 | 1,071,799 | SH | SOLE | 1,071,799 | 0 | 0 | |||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 115,945 | 73,383 | SH | SOLE | 73,383 | 0 | 0 | |||
| SURROZEN INC | COM | 86889P208 | 687,796 | 47,930 | SH | SOLE | 47,930 | 0 | 0 | |||
| SURROZEN INC | *W EXP 08/01/2 | 86889P117 | 700 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | |||
| TENAYA THERAPEUTICS INC | COM | 87990A106 | 417,314 | 291,828 | SH | SOLE | 291,828 | 0 | 0 | |||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 328,054 | 192,973 | SH | SOLE | 192,973 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 102,020 | 91,910 | SH | SOLE | 91,910 | 0 | 0 | |||
| XILIO THERAPEUTICS INC | COM | 98422T100 | 238,401 | 249,635 | SH | SOLE | 249,635 | 0 | 0 | |||
| Q32 BIO INC | COM | 746964105 | 460,626 | 133,903 | SH | SOLE | 133,903 | 0 | 0 | |||
| NU HLDGS LTD | ORD SHS CL A | G6683N103 | 1,124,972 | 108,588 | SH | SOLE | 108,588 | 0 | 0 | |||
| RILEY EXPLORATION PERMIAN IN | COM | 76665T102 | 239,496 | 7,503 | SH | SOLE | 7,503 | 0 | 0 | |||
| RAMACO RESOURCES INC | COM CL A | 75134P600 | 217,769 | 21,225 | SH | SOLE | 21,225 | 0 | 0 | |||
| SNOWFLAKE INC | CL A | 833445109 | 1,643,694 | 10,645 | SH | SOLE | 10,645 | 0 | 0 | |||